Characteristics of complete responders
. | Patient no. . | . | . | . | . | ||||
|---|---|---|---|---|---|---|---|---|---|
| Patient characteristics . | 2 . | 7 . | 8 . | 17 . | 12 . | ||||
| Age, y/sex | 13/F | 10/M | 12/M | 17/F | 18/M | ||||
| Diagnosis | ALL | ALL | ALL | T-ALL | AML | ||||
| Karyotype | t(9;22) | Random | Diploid | del(5)del(11) | Diploid | ||||
| Salvage status | 4 | 2 | 2 | 3 | 2 | ||||
| Prior BMT | Yes | No | No | No | No | ||||
| CRD1/CRD2, wk | 0/39 | 100/43 | 0 | 0 | 89/0 | ||||
| Clofarabine dose, mg/m2/d | 30 | 40 | 40 | 52 | 52 | ||||
| Course to CR | 2 | 2 | 1 | 3 | 3 | ||||
| CR duration, wk | 70 | 76+ | 57 | 11 | 64 | ||||
. | Patient no. . | . | . | . | . | ||||
|---|---|---|---|---|---|---|---|---|---|
| Patient characteristics . | 2 . | 7 . | 8 . | 17 . | 12 . | ||||
| Age, y/sex | 13/F | 10/M | 12/M | 17/F | 18/M | ||||
| Diagnosis | ALL | ALL | ALL | T-ALL | AML | ||||
| Karyotype | t(9;22) | Random | Diploid | del(5)del(11) | Diploid | ||||
| Salvage status | 4 | 2 | 2 | 3 | 2 | ||||
| Prior BMT | Yes | No | No | No | No | ||||
| CRD1/CRD2, wk | 0/39 | 100/43 | 0 | 0 | 89/0 | ||||
| Clofarabine dose, mg/m2/d | 30 | 40 | 40 | 52 | 52 | ||||
| Course to CR | 2 | 2 | 1 | 3 | 3 | ||||
| CR duration, wk | 70 | 76+ | 57 | 11 | 64 | ||||
CRD1/CRD2 indicates duration of first and second CRs.